Clinical Trial Update: Intravenous Administration of Microplasmin for Treatment of Acute Ischemic Stroke [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating intravenous microplasmin for acute ischemic stroke has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stroke

Drugs mentioned

• microplasmin (microplasmin)

Snippet

Sponsor: ThromboGenics | Conditions: Stroke, Acute | Phase 2 | Status: COMPLETED